Clinical applications of iron oxide nanoparticles for magnetic resonance imaging of brain tumors

Current Role of Anti-Angiogenic Strategies for Glioblastoma

(2014) Alissa A. Thomas et al.   CURRENT TREATMENT OPTIONS IN ONCOLOGY

Vessel calibre—a potential MRI biomarker of tumour response in clinical trials

(2014) Kyrre E. Emblem et al.   Nature Reviews Clinical Oncology

Current evidence of temozolomide and bevacizumab in treatment of gliomas

(2014) Danop Nanegrungsunk et al.   NEUROLOGICAL RESEARCH

A Randomized Trial of Bevacizumab for Newly Diagnosed Glioblastoma

(2014) Mark R. Gilbert et al.   NEW ENGLAND JOURNAL OF MEDICINE

Bevacizumab plus Radiotherapy–Temozolomide for Newly Diagnosed Glioblastoma

(2014) Olivier L. Chinot et al.   NEW ENGLAND JOURNAL OF MEDICINE

Multifunctional nanoparticles for brain tumor imaging and therapy

(2013) Yu Cheng et al.   ADVANCED DRUG DELIVERY REVIEWS

Safety and efficacy of total dose infusion of 1,020 mg of ferumoxytol administered over 15 min

(2013) Michael Auerbach et al.   AMERICAN JOURNAL OF HEMATOLOGY

Nanooncology: The future of cancer diagnosis and therapy

(2013) Avnesh S. Thakor et al.   CA-A CANCER JOURNAL FOR CLINICIANS

High-Resolution Steady-State Cerebral Blood Volume Maps in Patients with Central Nervous System Neoplasms Using Ferumoxytol, a Superparamagnetic Iron Oxide Nanoparticle

(2013) Csanad G Varallyay et al.   JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM

Vessel architectural imaging identifies cancer patient responders to anti-angiogenic therapy

(2013) Kyrre E Emblem et al.   NATURE MEDICINE

Nephrogenic Systemic Fibrosis in Denmark– A Nationwide Investigation

(2013) Tina R. Elmholdt et al.   PLoS One

Improved tumor oxygenation and survival in glioblastoma patients who show increased blood perfusion after cediranib and chemoradiation

(2013) T. T. Batchelor et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Neural Stem Cell-Mediated Enzyme/Prodrug Therapy for Glioma: Preclinical Studies

(2013) K. S. Aboody et al.   Science Translational Medicine

Inhibiting Vasculogenesis After Radiation: A New Paradigm to Improve Local Control by Radiotherapy

(2013) Brown J. Martin   SEMINARS IN RADIATION ONCOLOGY

Magnetic Resonance Imaging Tracking of Ferumoxytol-Labeled Human Neural Stem Cells: Studies Leading to Clinical Use

(2013) Margarita Gutova et al.   Stem Cells Translational Medicine

Toward absolute quantification of iron oxide nanoparticles as well as cell internalized fraction using multiparametric MRI

(2012) O. M. Girard et al.   Contrast Media & Molecular Imaging

Neural stem cell-mediated CE/CPT-11 enzyme/prodrug therapy in transgenic mouse model of intracerebellar medulloblastoma

(2012) M Gutova et al.   GENE THERAPY

Evaluation of novel combined carbogen USPIO (CUSPIO) imaging biomarkers in assessing the antiangiogenic effects of cediranib (AZD2171) in rat C6 gliomas

(2012) Jake S. Burrell et al.   INTERNATIONAL JOURNAL OF CANCER

Dual contrast perfusion MRI in a single imaging session for assessment of pediatric brain tumors

(2012) Eric M. Thompson et al.   JOURNAL OF NEURO-ONCOLOGY

High-resolution cerebral blood volume imaging in humans using the blood pool contrast agent ferumoxytol

(2012) Thomas Christen et al.   MAGNETIC RESONANCE IN MEDICINE

In vivo imaging of vessel diameter, size, and density: A comparative study between MRI and histology

(2012) Benjamin Lemasson et al.   MAGNETIC RESONANCE IN MEDICINE

Nanoparticles for imaging and treating brain cancer

(2012) Joseph D Meyers et al.   Nanomedicine

Pseudoprogression of Glioblastoma after Chemo- and Radiation Therapy: Diagnosis by Using Dynamic Susceptibility-weighted Contrast-enhanced Perfusion MR Imaging with Ferumoxytol versus Gadoteridol and Correlation with Survival

(2012) Seymur Gahramanov et al.   RADIOLOGY

Hydrogel Nanoparticles with Covalently Linked Coomassie Blue for Brain Tumor Delineation Visible to the Surgeon

(2012) Guochao Nie et al.   Small

Magnetic nanoparticles: an emerging technology for malignant brain tumor imaging and therapy

(2012) Mamta Wankhede et al.   Expert Review of Clinical Pharmacology

Ferumoxytol Use as an Intravenous Contrast Agent for Magnetic Resonance Angiography

(2011) Katie L Stabi et al.   ANNALS OF PHARMACOTHERAPY

Long term in vivo biotransformation of iron oxide nanoparticles

(2011) Michael Levy et al.   BIOMATERIALS

MRI of Tumor-Associated Macrophages with Clinically Applicable Iron Oxide Nanoparticles

(2011) H. E. Daldrup-Link et al.   CLINICAL CANCER RESEARCH

Direct visualization of non-human primate subcortical nuclei with contrast-enhanced high field MRI

(2011) Naoki Tani et al.   NEUROIMAGE

Vessel size index measurements in a rat model of glioma: comparison of the dynamic (Gd) and steady-state (iron-oxide) susceptibility contrast MRI approaches

(2011) Nicolas Pannetier et al.   NMR IN BIOMEDICINE

Improved Perfusion MR Imaging Assessment of Intracerebral Tumor Blood Volume and Antiangiogenic Therapy Efficacy in a Rat Model with Ferumoxytol

(2011) Seymur Gahramanov et al.   RADIOLOGY

EGFRvIII Antibody-Conjugated Iron Oxide Nanoparticles for Magnetic Resonance Imaging-Guided Convection-Enhanced Delivery and Targeted Therapy of Glioblastoma

(2010) C. G. Hadjipanayis et al.   CANCER RESEARCH

High-relaxivity contrast-enhanced magnetic resonance neuroimaging: a review

(2010) Frederik L. Giesel et al.   EUROPEAN RADIOLOGY

Preferential Effect of Synchrotron Microbeam Radiation Therapy on Intracerebral 9L Gliosarcoma Vascular Networks

(2010) Audrey Bouchet et al.   INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS

Inhibition of vasculogenesis, but not angiogenesis, prevents the recurrence of glioblastoma after irradiation in mice

(2010) Mitomu Kioi et al.   JOURNAL OF CLINICAL INVESTIGATION

Efficacy and safety of intratumoral thermotherapy using magnetic iron-oxide nanoparticles combined with external beam radiotherapy on patients with recurrent glioblastoma multiforme

(2010) Klaus Maier-Hauff et al.   JOURNAL OF NEURO-ONCOLOGY

Magnetic resonance imaging of intracranial tumors: intra-patient comparison of gadoteridol and ferumoxytol

(2010) E. Dosa et al.   NEURO-ONCOLOGY

Assessment of multiparametric MRI in a human glioma model to monitor cytotoxic and anti-angiogenic drug effects

(2010) Benjamin Lemasson et al.   NMR IN BIOMEDICINE

Uses of Nanoparticles for Central Nervous System Imaging and Therapy

(2009) J.M. Provenzale et al.   AMERICAN JOURNAL OF NEURORADIOLOGY

A “Vascular Normalization Index” as Potential Mechanistic Biomarker to Predict Survival after a Single Dose of Cediranib in Recurrent Glioblastoma Patients

(2009) A. Gregory Sorensen et al.   CANCER RESEARCH

Small Solutions for Big Problems: The Application of Nanoparticles to Brain Tumor Diagnosis and Therapy

(2009) DA Orringer et al.   CLINICAL PHARMACOLOGY & THERAPEUTICS

Safety and Tolerability of Ultrasmall Superparamagnetic Iron Oxide Contrast Agent

(2009) Hamm Bernd et al.   INVESTIGATIVE RADIOLOGY

High Resolution Ultra High Field Magnetic Resonance Imaging of Glioma Microvascularity and Hypoxia Using Ultra-Small Particles of Iron Oxide

(2009) Gregory A. Christoforidis et al.   INVESTIGATIVE RADIOLOGY

Dynamic MRI Using Iron Oxide Nanoparticles to Assess Early Vascular Effects of Antiangiogenic versus Corticosteroid Treatment in a Glioma Model

(2009) Csanad G Varallyay et al.   JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM

Characterization of Tumor Angiogenesis in Rat Brain Using Iron-Based Vessel Size Index MRI in Combination with Gadolinium-Based Dynamic Contrast-Enhanced MRI

(2009) Marine Beaumont et al.   JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM

Superparamagnetic Iron Oxide Nanoparticles: Diagnostic Magnetic Resonance Imaging and Potential Therapeutic Applications in Neurooncology and Central Nervous System Inflammatory Pathologies, a Review

(2009) Jason S Weinstein et al.   JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM

Relaxation effects of ferucarbotran-labeled mesenchymal stem cells at 1.5T and 3T: Discrimination of viable from lysed cells

(2009) Tobias D. Henning et al.   MAGNETIC RESONANCE IN MEDICINE

MGMT promoter methylation in malignant gliomas: ready for personalized medicine?

(2009) Michael Weller et al.   Nature Reviews Neurology

Differentiation of Recurrent Glioblastoma Multiforme from Radiation Necrosis after External Beam Radiation Therapy with Dynamic Susceptibility-weighted Contrast-enhanced Perfusion MR Imaging

(2009) Ramon F. Barajas et al.   RADIOLOGY

In vivo visualization of macrophage infiltration and activity in inflammation using magnetic resonance imaging

(2009) Nicolau Beckmann et al.   Wiley Interdisciplinary Reviews-Nanomedicine and Nanobiotechnology

Characterisation of tumour vasculature in mouse brain by USPIO contrast-enhanced MRI

(2008) G Gambarota et al.   BRITISH JOURNAL OF CANCER

Matrix Metalloproteinase-9 Is Required for Tumor Vasculogenesis but Not for Angiogenesis: Role of Bone Marrow-Derived Myelomonocytic Cells

(2008) G-One Ahn et al.   CANCER CELL

Ultrasmall superparamagnetic iron oxides (USPIOs): a future alternative magnetic resonance (MR) contrast agent for patients at risk for nephrogenic systemic fibrosis (NSF)?

(2008) Edward A. Neuwelt et al.   KIDNEY INTERNATIONAL

MRI with a lymph-node-specific contrast agent as an alternative to CT scan and lymph-node dissection in patients with prostate cancer: a prospective multicohort study

(2008) Roel AM Heesakkers et al.   LANCET ONCOLOGY

Brain tumor vessel response to synchrotron microbeam radiation therapy: a short-termin vivostudy

(2008) Raphaël Serduc et al.   PHYSICS IN MEDICINE AND BIOLOGY

Gliomas: Predicting Time to Progression or Survival with Cerebral Blood Volume Measurements at Dynamic Susceptibility-weighted Contrast-enhanced Perfusion MR Imaging

(2008) Meng Law et al.   RADIOLOGY